Publications

  1. AG. Gharavi, K. Kiryluk, M. Choi, Y. Li, P. Hou, S. Sanna Cherchi, M. Salvadori et al. Genome Wide Association Study Identifies Five Susceptibility Loci for IgA Nephropathy: the Most Common Form o f Glomerulonephritis. Nature Genetics 43: 321-327; 2011
  2. M. Salvadori, A. Larti, G. Rosso, M. Zanazzi, L. Di Maria, E. Bertoni Cyclosporine Very Low Exposure with Everolimus High Exposure is Associated with Better Outcomes in Renal Transplant Patients with Respect to Standard Treatment: Results at two Years Transplant Proc in press; 2010
  3. M. Salvadori , G. Rosso , P. Carta , A. Larti ,L. di Maria , E. Bertoni . Donors positive for hepatitis B core antibodies in nonliver transplantations. Transplant Proc 2011; 43: 277-279.
  4. S.Mazzaferro , D. Brancaccio ,P. Messa, VE. Andreucci, G. Bellinghieri, R. Bigazzi, P.  Bolasco, AM. Costanzo , U.  di Luzio Paparatti, G. Cannella, M. Salvadori; FARO Study Group. Management of secondary hyperparathyroidism in Italy: results of the Italian FARO survey. J Nephrol. 2011 Mar-Apr;24(2):225-35
  5. M. Salvadori, E. Bertoni. Long term Outcome of Everolimus Treatment in Transplant Patients Transplant Research and Risk Management 3: 1-14; 2011
  6. L. Moscarelli, M. Zanazzi, E. Bertoni, L. Caroti, G. Rosso, S. Farsetti, F. Annunziata, N. Paudice, M. Salvadori  Renin Angiotensin System Blockade and Activated Vitamin D as a Means of Preventing Deep Vein Thrombosis in Renal Transplant Recipients Clin Nephrol 75: 440-450, 2011
  7. C. Ponticelli, M. Salvadori, MP, Scolari, F. Citterio,P. Rigotti, A. Veneziano, M. Bartezaghi Everolimus and Minimization of Cyclosporine in Renal TRansplantation: 24-month Follow-Up of the Everest Study Transplantation 91: 72-73, 2011
  8. F. Mallamaci, P. Ruggenenti, A. Perna, D. Leonardis, R. Tripepi, G. Tripepi, G. Remuzzi, C. Zoccali, M. Salvadori; REIN Study Group ACE Inhibition is Renoprotective among Obese Patients with Proteinuria J Am Soc Nephrol 22: 1122-1128, 2011
  9.   U. Heeman, D. Abramowicz, G. Spasovsky, R. Vanholder, M. Salvadori; European Renal Best Practice Work Group on Kidney Transplantation. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Guidelines on Kidney Transplantation: a European Renal Best Practice (ERBP) Position Statement. Nephrol Dial Transplant 26: 2099-2106, 2011
  10. 209) C. Ponticelli, M. Salvadori, R.Coppo. The Kidney, a Victim and Culprit of Autoimmune and Alloimmune Responses Nephron Clin Pract 119: 200-204, 2011
  11. A. Cania, F. Bergesio, G. Curciarello, F. Perfetto, AM Ciciani, S. Nigrelli, B. Minuti, AL. Caldini, S. Di Lollo, C. Nozzoli, M. Salvadori The Florence Register of Amyloidosis: 20 Years’ Experience in  the Diagnosis and Treatment of the Disease in the Florence District Area Amyloid 18: S81-S83, 2011.
  12. D. Brancaccio, M. Cozzolino, G. Cannella, P. Messa, M. Bonomimi, G. Cancarini, MR. Caruso, C. Cascone, AM Costanzo, M. Salvadori; FARO Study Group
  13. Secondary Hyperparathyroidism in Chronic Dialysis Patients: Results of the Italian FARO Survey on Treatment and Mortality. Blood Purif. 32: 124-32, 2011.
  14. C. Zoccali, P. Ruggenenti, A. Perna, D. Leonardis, R. Tripepi, G. Tripepi, F. Mallamaci, G. Remuzzi, M. Salvadori; REIN Study Group. Phosphate May Promote CKD Progression and Attenuate Renoprotective Effect of ACE Inhibition J Am Soc Nephrol 22: 1923-30, 2011
  15. M. Salvadori What is the Purpose of Launching the World Journal of Transplantation? World J Transplant 1: 1-3, 2011
  16. Fatini C, Sticchi E, Cesari F, Gori AM, Cioni G, De Stefano M, Bertoni E, Paudice N, Salvadori M, Zanazzi M, Abbate R. Relationship Among Endothelial Response to Hyperemia, Bone  arrow- erived Progenitor Cells, and Parathyroid Hormone in Renal Transplantation. Transplantation 2012; 93: 835-841
  17. Cooper M, Salvadori M, Budde K, Oppenheimer F, Sollinger H, Zeier M Enteric-coated Mycophenolate Sodiun Immunosuppression in renal Transplant Patients: Efficacy and Dosing Transplant Rev 2012; 26: 233-240
  18. Salvadori M, Bertoni E. Renal Transplant Allocation Criteria, Desensitization Strategies and Immunosuppressive Therapy in Retransplant Renal Patients Journal of Nephrol 2012; 25: 890-899
  19. Caroti L, Zanazzi M, Paudice N, Tsalouchos A, Carta P, Larti A, Pimpinelli N, Moscarelli L, Salvadori M, Bertoni E. Conversion from Calcineurin Inhibitors to Everolimus with Low-Dose Cyclosporine in Renal Transplant Recipients with Squamous Cell Carcinoma of the Skin. Transplant Proc. 2012 Sep;44(7):1926-7.
  20. Paudice N, Zanazzi M, Agostini S, Bertelli E, Caroti L, Carta P, Moscarelli L, Tsalouchos A, Salvadori M, Bertoni E. Contrast-Enhanced Ultrasound Assessment of Complex Cystic Lesions in Renal Transplant Recipients with Acquired Cystic Kidney Disease: Preliminary Experience. Transplant Proc. 2012 Sep;44(7):1928-9
  21. Cozzolino M, Brancaccio D, Cannella G, Messa P, Gesualdo L, Marangella M, LoDeserto C, Pozzato M, Rombolà G, Costanzo AM, di Luzio Paparatti U, Mazzaferro F, Salvadori M; FARO Study Group VDRA Therapy is Associated with Improved Survival in Dialysis Patients with Serum Intact PTH <150 pg/ml: Results of the Italian FARO Survey Nephrol Dial Transplant 2012; 27: 3588-3594
  22. Salvadori M.  Antineoplasic effects of mammalian target of rapamycin inhibitors World J Transplant 2012; 2: 69-78
  23. Salvadori M, Bertoni E. Is it time to give up with calcineurin inhibitors (CNIs) in kidney Transplantation? World J Transplant 2013; 3: 7-25
  24. Salvadori M, Bertoni E. Update on hemolytic uremic syndrome (HUS): diagnostic and  therapeutic recommendations World J Nephrol 2013; 2: 56-76
  25. Abramowicz D, Cochat P, Claas F, Dudley C, Harden P, Heeman U, Hourmont M, Maggiore U, Pascual J, Salvadori M, Spasovsky G, Squifflet JP, Steiger J, Torres A, Van Biesen W, Viklicky O, Zeier M. ERBP Guideline on the management and evaluation of the kidney donor and recipient Nephrol Dial Transpl 2013; 28: 1-71
  26. Salvadori M, Bertoni E Acute Antibody-Mediated Rejection in Kidney Transplantation: Clinical and Therapeutic Aspects Journal Nephrology and Therapeutics 2013; 4
  27. Coppo R, Troyanov S, Cattran D, Cook T, Freehally J, Emma F, Rollino C, Salvadori M, et al Validation of the Oxford Classification of IgA Nephropathy in Cohorts with Different Presentations and Treatments. Kidney Int 2014; 86: 828-836
  28. Salvadori M, Bertoni E. Impact of donor specific antibodies on kidney graft outcome: pathophysiology, clinical, therapy World J Transplant 2014; 4: 1-17
  29. Bolignano D, Locatelli F, Zoccali C, Maggiore U, Salvadori M. Linee Guida European Renal Best Practice Della Valutazione ed Assistenza Peri-Operatoria del Donatore e Ricevente di Trapiento Renale Giornale Italiano di Nefrologia 2014; 31: 
  30. Salvadori M, Bertoni E. Chronic Renal Allograft Dysfunction Antibody Mediated: An Up-To-Date European Medical Journal- Nephrology 2014; 1:91-99
  31. Muhlbacher F, Neumayer HH, del Castillo D, Stefoni S, Zygmunt AJ, Budde K, Salvadori M.  The Efficacy and Safety of Cyclosporine Reduction in de Novo Renal Allograft Patients Receiving Sirolimus and Corticosteroids: Results from an Open-label Comparative Study. Transpl Int. 2014;27(2):176-86
  32. Cochat P, Abramowicz D, Claas F, Dudley C, Harden P, Heeman U, Hourmant M, Maggiore U, Pascual J, Salvadori M, Spasovsky G, Squifflet JP, Steiger J, Torres A, Vanholder R, Van Biesen W, Viklicky O, Zeier M, Nagler E, Recommendations du Group ERBP sur l’Evaluation du Donneur de Rein et du Receveur, et de Soins Perioperatoires Nephrologie & Therapeutics 2014; 10: 427-432
  33. Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M, Fasel D, Lata S,Prakash P, Shapiro S, Fischman C, Salvadori M, Gharawi A Novel GWAS Loci for IgA Nephropathy Implicate Immunity Against Intestinal Pathogens  Nature Genetics 2014; 46: 1187-1196
  34. Pascual J, Abramowicz D, Cochat P, Claas F, Dudley C, Harden P, Heeman U, Hourmant M, Maggiore U, Salvadori M, Spasovski G, Squif Et JP, Steiger J, Torres A, Vanholder R, Van Biesen W, Viklicky O, Zeier M, Nagler E. European Renal Best Practice Guideline on the Management and Evaluation of the Kidney Donor and Recipient. Nefrologia. 2014; 34: 293-301
  35. Abramowicz D, Cochat P, Claas FH, Heemann U, Pascual J, Dudley C, Harden P, Hourmant M, Maggiore U, Salvadori M, Spasovski G, Squifflet JP, Steiger J, Torres A, Viklicky O, Zeier M, Vanholder R, Van Biesen W, Nagler E. European Renal Best Practice Guideline on Kidney Donor and Recipient Evaluation and Perioperative Care. Nephrol Dial Transpl 2014; Epub ahead of print
  36. Salvadori M, Bertoni E. What’s new in clinical solid organ transplantation by 2013 World Journal Transplantation 2014; 4:243-266 236) Salvadori M, Rosso G, Bertoni E. Complement involvement in kidney diseases: From physiopatology to therapeutical targeting World Journal Nephrology 2015; 4: 169-184
  37. Tesar V, Troyanov S, Bellur S, Verhave JC, Salvadori M et al.  Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study J Am Soc Nephrol 2015; epub ahead of print

Maurizio Salvadori

Professor of Nephrology

 

  • : 39 055 597151
    Fax: 39 055 597151
  • DEPARTMENTDepartment of Transplantation
    Careggi University Hospital Florence
  • COUNTRY Italy